ALTIMMUNE, INC. Goodwill, Acquired During Period
ALTIMMUNE, INC. (ALT) reported Goodwill, Acquired During Period of $490.68 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-27.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2020-03-27
- ALTIMMUNE, INC. goodwill, acquired during period for the quarter ending 2018-12-31 was $0.00.
- ALTIMMUNE, INC. goodwill, acquired during period for the quarter ending 2018-09-30 was $0.00.
- ALTIMMUNE, INC. goodwill, acquired during period for the quarter ending 2018-06-30 was $0.00.
- ALTIMMUNE, INC. goodwill, acquired during period for the quarter ending 2018-03-31 was $490.68K.
- ALTIMMUNE, INC. goodwill, acquired during period for fiscal 2018 was $490.68K, a 96.85% decline from fiscal 2017.
- ALTIMMUNE, INC. goodwill, acquired during period for fiscal 2017 was $15.57M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $0.00 derived: sum of 2 quarters · filed 2020-03-27 | $0.00 derived: sum of 3 quarters · filed 2020-03-27 | $490.68K 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $490.68K 10-Q · filed 2019-11-13 | $490.68K derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $490.68K 10-Q · filed 2019-08-13 | $490.68K derived: sum of 3 quarters · filed 2019-08-13 | $441.44K derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $490.68K 10-Q · filed 2019-05-14 | $490.68K derived: sum of 2 quarters · filed 2019-05-14 | $441.44K derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$49.23K derived: sum of 2 quarters · filed 2019-04-01 | $15.57M 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$49.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $15.57M 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | $15.62M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |